Charles F. Shaefer

948 total citations · 1 hit paper
18 papers, 702 citations indexed

About

Charles F. Shaefer is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Charles F. Shaefer has authored 18 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Charles F. Shaefer's work include Diabetes Management and Research (16 papers), Diabetes Treatment and Management (13 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (6 papers). Charles F. Shaefer is often cited by papers focused on Diabetes Management and Research (16 papers), Diabetes Treatment and Management (13 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (6 papers). Charles F. Shaefer collaborates with scholars based in United States, Thailand and Canada. Charles F. Shaefer's co-authors include James J. Chamberlain, Andrew S. Rhinehart, Pamela Kushner, Richard Aguilar, John E. Anderson, Guillermo E. Umpierrez, NEIL SKOLNIK, Eugene E. Wright, Timothy S. Bailey and Jay H. Shubrook and has published in prestigious journals such as Annals of Internal Medicine, Diabetes Obesity and Metabolism and Diabetes/Metabolism Research and Reviews.

In The Last Decade

Charles F. Shaefer

18 papers receiving 685 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes

2016 475 citations James J. Chamberlain, Andrew S. Rhinehart et al. Annals of Internal Medicine profile →

Peers

Countries citing papers authored by Charles F. Shaefer

Since Specialization

Citations

This map shows the geographic impact of Charles F. Shaefer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles F. Shaefer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles F. Shaefer more than expected).

Fields of papers citing papers by Charles F. Shaefer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles F. Shaefer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles F. Shaefer. The network helps show where Charles F. Shaefer may publish in the future.

Co-authorship network of co-authors of Charles F. Shaefer

This figure shows the co-authorship network connecting the top 25 collaborators of Charles F. Shaefer. A scholar is included among the top collaborators of Charles F. Shaefer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles F. Shaefer. Charles F. Shaefer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	When basal insulin is not enough: A dose–response relationship between insulin glargine 100 units/mL and glycaemic control 2019 ·Diabetes Obesity and Metabolism ·Guillermo E. Umpierrez, NEIL SKOLNIK, (unknown), Louise Traylor, Jason Chao, Charles F. Shaefer	17
2	Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategies 2017 ·Journal of Diabetes ·Guillermo E. Umpierrez, Timothy S. Bailey, (unknown), Charles F. Shaefer, Jay H. Shubrook, NEIL SKOLNIK	21
3	Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus 2016 ·Diabetes Therapy ·John E. Anderson, Eugene E. Wright, Charles F. Shaefer	14
4	Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes breakdown → 2016 ·Annals of Internal Medicine ·James J. Chamberlain, Andrew S. Rhinehart, Charles F. Shaefer, (unknown)	475
5	Hypoglycemia and diabetes: increased need for awareness 2016 ·Current Medical Research and Opinion ·Charles F. Shaefer, (unknown), (unknown)	14
6	Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies 2016 ·Clinical Diabetes ·Charles F. Shaefer	5
7	The importance of postprandial glycemic control: optimizing add-on therapy to basal insulin 2015 ·Postgraduate Medicine ·Charles F. Shaefer, John E. Anderson	10
8	User’s guide to mechanism of action and clinical use of GLP-1 receptor agonists 2015 ·Postgraduate Medicine ·Charles F. Shaefer, Pamela Kushner, Richard Aguilar	90
9	Fasting Versus Postprandial Hyperglycemia as a Treatment Target to Lower Elevated Hemoglobin A1C 2015 ·Endocrine Practice ·Charles F. Shaefer, (unknown), Aleksandra Vlajnic, Rong Zhou, Andrés Digenio	5
10	Weight Change in Patients with Type 2 Diabetes Starting Basal Insulin Therapy: Correlates and Impact on Outcomes 2014 ·Postgraduate Medicine ·Charles F. Shaefer, (unknown), George Dailey, (unknown), Aleksandra Vlajnic, (unknown), John A. Stewart, Rong Zhou	14
11	Patterns of postprandial hyperglycemia after basal insulin therapy: individual and regional differences 2014 ·Diabetes/Metabolism Research and Reviews ·Charles F. Shaefer, (unknown), Andrés Digenio, Aleksandra Vlajnic, Rong Zhou, Barbara Ameer, Matthew C. Riddle	4
12	Using a Quantitative Measure of Diabetes Risk in Clinical Practice to Target and Maximize Diabetes Prevention Interventions 2013 ·Clinical Diabetes ·(unknown), Charles F. Shaefer, Christopher G. Parkin, Steven V. Edelman	10
13	The pen is mightier than the sword 2009 ·Charles F. Shaefer	6
14	Implications of the ADA/EASD consensus algorithm for treatment of type 2 diabetes mellitus for primary care practitioners: Four pivotal points 2008 ·Charles F. Shaefer	1
15	Patient and Physician Barriers to Instituting Insulin Therapy: A Case-Based Overview 2007 ·Charles F. Shaefer	1
16	Clinical inertia: Overcoming a major barrier to diabetes management 2006 ·Charles F. Shaefer	5
17	Respective roles of gastric emptying and alcohol metabolism in the gender difference of ethanol’s first-pass metabolism 1998 ·Chaim S. Abittan, Enrique Baraona, Gabriele Pozzato, Michelle Moretti, Zev W. Chayes, Charles F. Shaefer, C S Lieber	1
18	Melioidosis: Recrudescence with a Strain Resistant to Multiple Antimicrobials ¹ 1983 ·American Review of Respiratory Disease ·Charles F. Shaefer, (unknown), J. P. Rissing	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact